TrialCancer reports (Hoboken, N.J.)2022

Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer.

Ahmad Ameri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.